Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Herting

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|July 27, 2022
Multi-centre randomised trial of invasive and less invasive surfactant delivery methods showed similar spirometry results at 5-9 years of ageWolfgang Göpel, Angela Kribs, Claudia Roll, et al.
Antimicrobial Resistance and Infection Control|August 27, 2020
Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organismsChristoph Härtel, Kirstin Faust, Ingmar Fortmann, et al.
Cell Reports|October 25, 2025
Bacterial metabolite patterns of infants receiving multi-strain probiotics and risk of late-onset sepsisSilvio Waschina, Julia Pagel, Karsten Seeger, et al.
The Pediatric Infectious Disease Journal|September 14, 2013
Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal NetworkBirte Tröger, Wolfgang Göpel, Kirstin Faust, et al.
BMJ Open|November 23, 2019
Efficacy of <i>Bifidobacterium longum, B. infantis and Lactobacillus acidophilus</i> probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocolJanina Marißen, Annette Haiß, Claudius Meyer, et al.
Vaccines|January 24, 2025
Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term OutcomesMarie-Theres Dammann, Hannah Kraft, Guido Stichtenoth, et al.
Molecular and Cellular Pediatrics|April 10, 2026
Risk factors and outcomes of delayed completion of the hexavalent 3 + 1 immunisation series in German preterm infants - an observational studyHannah Kraft, Marie-Theres Dammann, Kathrin Hanke, et al.
Vaccines|June 2, 2021
Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine VaccinationsIngmar Fortmann, Marie-Theres Dammann, Alexander Humberg, et al.
Nutrients|April 3, 2020
<i>Lactobacillus Acidophilus/Bifidobacterium Infantis</i> Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human MilkIngmar Fortmann, Janina Marißen, Bastian Siller, et al.
Plos One|July 7, 2012
Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal NetworkChristoph Härtel, Kirstin Faust, Stefan Avenarius, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Acta Paediatrica (Oslo, Norway : 1992)|July 27, 2022
Multi-centre randomised trial of invasive and less invasive surfactant delivery methods showed similar spirometry results at 5-9 years of ageWolfgang Göpel, Angela Kribs, Claudia Roll, et al.
Antimicrobial Resistance and Infection Control|August 27, 2020
Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organismsChristoph Härtel, Kirstin Faust, Ingmar Fortmann, et al.
Cell Reports|October 25, 2025
Bacterial metabolite patterns of infants receiving multi-strain probiotics and risk of late-onset sepsisSilvio Waschina, Julia Pagel, Karsten Seeger, et al.
The Pediatric Infectious Disease Journal|September 14, 2013
Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal NetworkBirte Tröger, Wolfgang Göpel, Kirstin Faust, et al.
BMJ Open|November 23, 2019
Efficacy of <i>Bifidobacterium longum, B. infantis and Lactobacillus acidophilus</i> probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocolJanina Marißen, Annette Haiß, Claudius Meyer, et al.
Vaccines|January 24, 2025
Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term OutcomesMarie-Theres Dammann, Hannah Kraft, Guido Stichtenoth, et al.
Molecular and Cellular Pediatrics|April 10, 2026
Risk factors and outcomes of delayed completion of the hexavalent 3 + 1 immunisation series in German preterm infants - an observational studyHannah Kraft, Marie-Theres Dammann, Kathrin Hanke, et al.
Vaccines|June 2, 2021
Five Year Follow Up of Extremely Low Gestational Age Infants after Timely or Delayed Administration of Routine VaccinationsIngmar Fortmann, Marie-Theres Dammann, Alexander Humberg, et al.
Nutrients|April 3, 2020
<i>Lactobacillus Acidophilus/Bifidobacterium Infantis</i> Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human MilkIngmar Fortmann, Janina Marißen, Bastian Siller, et al.
Plos One|July 7, 2012
Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal NetworkChristoph Härtel, Kirstin Faust, Stefan Avenarius, et al.
Pageof 15